Meyers, C. D., Tremblay, K., Amer, A., Chen, J., Jiang, L., & Gaudet, D. (2015). Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome. Lipids Health Dis.
Chicago ZitierstilMeyers, Charles Daniel, Karine Tremblay, Ahmed Amer, Jin Chen, Liewen Jiang, und Daniel Gaudet. "Effect of the DGAT1 Inhibitor Pradigastat On Triglyceride and ApoB48 Levels in Patients With Familial Chylomicronemia Syndrome." Lipids Health Dis 2015.
MLA ZitierstilMeyers, Charles Daniel, et al. "Effect of the DGAT1 Inhibitor Pradigastat On Triglyceride and ApoB48 Levels in Patients With Familial Chylomicronemia Syndrome." Lipids Health Dis 2015.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.